EUVIMEDOtkrijte EUVIMED
Open access · CC BY 4.0

Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate

Hasim Bakbak, Gurpremjit Singh, Ahmad Abdelaziz, Adam Williams, Juanita Velasquez Ospina, Jonathan E Katz, Robert Marcovich, Alan Jerome Wein, Hemendra N Shah

BJUI Compass · 2026-07 · 7 (7)

DOI: 10.1002/bco2.70244 ↗

At a glance

Journal article in BJUI Compass, published online on 2026-07-08. Written by Hasim Bakbak and 8 co-authors. Institution: Desai Sethi Urology Institute University of Miami Miller School of Medicine Miami Florida USA. Cited 1 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCATS NIH HHS.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Objectives

This work aimed to evaluate the safety and efficacy of holmium laser enucleation of the prostate across different degrees of frailty using the 11‐item and 5‐item modified frailty indices and to compare perioperative and postoperative outcomes across multiple frailty thresholds. Materials and Methods We retrospectively reviewed patients who underwent HoLEP at our institution between July 2017 and August 2025. Frailty was assessed using mFI‐11 (cutoffs ≥0.18, ≥0.27, ≥0.36) and mFI‐5 (≥0.40). Perioperative variables, functional outcomes, and postoperative complications were compared. Agreement between frailty definitions was assessed using Cohen's kappa. Logistic regression was used to evaluate complication risk.

Results

Among 857 patients, overall frailty burden was low ranging from 16.2% with mFI‐11 ≥0.36 to 52.6% with mFI‐11 ≥0.18, and 27.5% by mFI‐5 ≥0.40. Functional outcomes improved in all groups, though patients defined as frail by mFI‐11 ≥0.36 demonstrated less improvement in IPSS at 1 year and lower Qmax at select time points. Major complications were uncommon and did not demonstrate a consistent frailty gradient. Transfusion risk was higher only at mFI‐11 ≥0.36. Urinary tract infection showed a dose–response relationship with increasing mFI‐11, with approximately a 20% increase in odds per one‐point increase.

Conclusions

HoLEP is safe and effective across frailty definitions. Frailty cutoff selection meaningfully influences risk stratification, with mFI‐11 ≥0.36 providing the most clinically informative discrimination.

Subjects

Author keywords

HoLEPbenign prostatic hyperplasiacomplicationselderlyenlarged prostatefrailtyoctogenarians

Authors and institutions

  • Desai Sethi Urology Institute University of Miami Miller School of Medicine Miami Florida USA.

Funding

  • NCATS NIH HHS

Cite

APA

Bakbak, H., Singh, G., Abdelaziz, A., Williams, A., Velasquez Ospina, J., Katz, J. E., Marcovich, R., Wein, A. J., & Shah, H. N. (2026). Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate. BJUI Compass, 7(7). https://doi.org/10.1002/bco2.70244

Vancouver

Bakbak H, Singh G, Abdelaziz A, Williams A, Velasquez Ospina J, Katz JE, et al. Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate. BJUI Compass. 2026;7(7). doi:10.1002/bco2.70244

BibTeX
@article{Bakbak2026,
  author = {Bakbak, Hasim and Singh, Gurpremjit and Abdelaziz, Ahmad and Williams, Adam and Velasquez Ospina, Juanita and Katz, Jonathan E and Marcovich, Robert and Wein, Alan Jerome and Shah, Hemendra N},
  title = {Comparative performance of mFI‐5 and mFI‐11 thresholds in predicting outcomes after holmium laser enucleation of the prostate},
  journal = {BJUI Compass},
  year = {2026},
  volume = {7},
  number = {7},
  doi = {10.1002/bco2.70244}
}
Start for free →